79 related articles for article (PubMed ID: 28222666)
1. Dynamic tracing for epidermal growth factor receptor mutations in urinary circulating DNA in gastric cancer patients.
Shi XQ; Xue WH; Zhao SF; Zhang XJ; Sun W
Tumour Biol; 2017 Feb; 39(2):1010428317691681. PubMed ID: 28222666
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor mutation in gastric cancer.
Liu Z; Liu L; Li M; Wang Z; Feng L; Zhang Q; Cheng S; Lu S
Pathology; 2011 Apr; 43(3):234-8. PubMed ID: 21436633
[TBL] [Abstract][Full Text] [Related]
3. A noninvasive system for monitoring resistance to epidermal growth factor receptor tyrosine kinase inhibitors with plasma DNA.
Nakamura T; Sueoka-Aragane N; Iwanaga K; Sato A; Komiya K; Abe T; Ureshino N; Hayashi S; Hosomi T; Hirai M; Sueoka E; Kimura S
J Thorac Oncol; 2011 Oct; 6(10):1639-48. PubMed ID: 21921847
[TBL] [Abstract][Full Text] [Related]
4. Application of a highly sensitive detection system for epidermal growth factor receptor mutations in plasma DNA.
Nakamura T; Sueoka-Aragane N; Iwanaga K; Sato A; Komiya K; Kobayashi N; Hayashi S; Hosomi T; Hirai M; Sueoka E; Kimura S
J Thorac Oncol; 2012 Sep; 7(9):1369-81. PubMed ID: 22858585
[TBL] [Abstract][Full Text] [Related]
5. Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer.
Kimura H; Kasahara K; Kawaishi M; Kunitoh H; Tamura T; Holloway B; Nishio K
Clin Cancer Res; 2006 Jul; 12(13):3915-21. PubMed ID: 16818687
[TBL] [Abstract][Full Text] [Related]
6. Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas.
Taniguchi K; Uchida J; Nishino K; Kumagai T; Okuyama T; Okami J; Higashiyama M; Kodama K; Imamura F; Kato K
Clin Cancer Res; 2011 Dec; 17(24):7808-15. PubMed ID: 21976538
[TBL] [Abstract][Full Text] [Related]
7. Comparison of EGFR mutation status between plasma and tumor tissue in non-small cell lung cancer using the Scorpion ARMS method and the possible prognostic significance of plasma EGFR mutation status.
Duan H; Lu J; Lu T; Gao J; Zhang J; Xu Y; Wang M; Wu H; Liang Z; Liu T
Int J Clin Exp Pathol; 2015; 8(10):13136-45. PubMed ID: 26722512
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of treatment responses and clonal evolution of tumor cells by circulating tumor DNA of heterogeneous mutant EGFR genes in lung cancer.
Imamura F; Uchida J; Kukita Y; Kumagai T; Nishino K; Inoue T; Kimura M; Oba S; Kato K
Lung Cancer; 2016 Apr; 94():68-73. PubMed ID: 26973209
[TBL] [Abstract][Full Text] [Related]
9. Urinary measurement of circulating tumor DNA for treatment monitoring and prognosis of metastatic colorectal cancer patients.
Song T; Mao F; Shi L; Xu X; Wu Z; Zhou J; Xiao M
Clin Chem Lab Med; 2018 Dec; 57(2):268-275. PubMed ID: 30016269
[TBL] [Abstract][Full Text] [Related]
10. Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples.
Ishii H; Azuma K; Sakai K; Kawahara A; Yamada K; Tokito T; Okamoto I; Nishio K; Hoshino T
Oncotarget; 2015 Oct; 6(31):30850-8. PubMed ID: 26334838
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor structural alterations in gastric cancer.
Moutinho C; Mateus AR; Milanezi F; Carneiro F; Seruca R; Suriano G
BMC Cancer; 2008 Jan; 8():10. PubMed ID: 18199332
[TBL] [Abstract][Full Text] [Related]
12. Detection of epidermal growth factor receptor mutations in plasma by mutant-enriched PCR assay for prediction of the response to gefitinib in patients with non-small-cell lung cancer.
He C; Liu M; Zhou C; Zhang J; Ouyang M; Zhong N; Xu J
Int J Cancer; 2009 Nov; 125(10):2393-9. PubMed ID: 19530244
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor mutation status in cell-free DNA supernatant of bronchial washings and brushings.
Kawahara A; Fukumitsu C; Taira T; Abe H; Takase Y; Murata K; Yamaguchi T; Azuma K; Ishii H; Takamori S; Akiba J; Hoshino T; Kage M
Cancer Cytopathol; 2015 Oct; 123(10):620-8. PubMed ID: 26235264
[TBL] [Abstract][Full Text] [Related]
14. Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial.
Karachaliou N; Mayo-de las Casas C; Queralt C; de Aguirre I; Melloni B; Cardenal F; Garcia-Gomez R; Massuti B; Sánchez JM; Porta R; Ponce-Aix S; Moran T; Carcereny E; Felip E; Bover I; Insa A; Reguart N; Isla D; Vergnenegre A; de Marinis F; Gervais R; Corre R; Paz-Ares L; Morales-Espinosa D; Viteri S; Drozdowskyj A; Jordana-Ariza N; Ramirez-Serrano JL; Molina-Vila MA; Rosell R;
JAMA Oncol; 2015 May; 1(2):149-57. PubMed ID: 26181014
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of switching to a second EGFR-TKI after a severe AE related to a first EGFR-TKI in EGFR-mutated NSCLC.
Takeda M; Okamoto I; Tsurutani J; Oiso N; Kawada A; Nakagawa K
Jpn J Clin Oncol; 2012 Jun; 42(6):528-33. PubMed ID: 22457323
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of KRAS status in circulating plasma DNA compared to archival tumour tissue from patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor therapy.
Spindler KL; Pallisgaard N; Appelt AL; Andersen RF; Schou JV; Nielsen D; Pfeiffer P; Yilmaz M; Johansen JS; Hoegdall EV; Jakobsen A; Jensen BV
Eur J Cancer; 2015 Nov; 51(17):2678-85. PubMed ID: 26508156
[TBL] [Abstract][Full Text] [Related]
17. Quantification of plasma cell-free DNA in patients with gastric cancer.
Sai S; Ichikawa D; Tomita H; Ikoma D; Tani N; Ikoma H; Kikuchi S; Fujiwara H; Ueda Y; Otsuji E
Anticancer Res; 2007; 27(4C):2747-51. PubMed ID: 17695442
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor (EGFR): mutational and protein expression analysis in gastric cancer.
Mammano E; Belluco C; Sciro M; Mencarelli R; Agostini M; Michelotto M; Marchet A; Nitti D
Anticancer Res; 2006; 26(5A):3547-50. PubMed ID: 17094480
[TBL] [Abstract][Full Text] [Related]
19. Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer.
Mu XL; Li LY; Zhang XT; Wang MZ; Feng RE; Cui QC; Zhou HS; Guo BQ
Clin Cancer Res; 2005 Jun; 11(12):4289-94. PubMed ID: 15958609
[TBL] [Abstract][Full Text] [Related]
20. The close correlation between 8-hydroxy-2'-deoxyguanosine and epidermal growth factor receptor activating mutation in non-small cell lung cancer.
Kawahara A; Azuma K; Hattori S; Nakashima K; Basaki Y; Akiba J; Takamori S; Aizawa H; Yanagawa T; Izumi H; Kohno K; Kono S; Kage M; Kuwano M; Ono M
Hum Pathol; 2010 Jul; 41(7):951-9. PubMed ID: 20236686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
